What is the role of oral anticoagulation in patients with rheumatic mitral valve disease without AF and no other likely cause for their symptoms?
In patients with rheumatic mitral valve disease without AF and no other likely cause for their symptoms, the role of oral anticoagulation has not been adequately investigated. Further studies are needed to determine the potential benefit of switching to oral anticoagulation with warfarin or a DOAC.